ANKTIVA Trademark

Trademark Overview


On Thursday, September 1, 2022, a trademark application was filed for ANKTIVA with the United States Patent and Trademark Office. The USPTO has given the ANKTIVA trademark a serial number of 97575663. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Altor BioScience, LLC. The ANKTIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases for clinical, medicinal, therapeutic, vaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, for clinical, medicinal, theapeutic, vaccine, and vaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseases, namely, cancer, and infectious diseases; biological preparations for medical purposes, namely, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseases, namely, c...
anktiva

General Information


Serial Number97575663
Word MarkANKTIVA
Filing DateThursday, September 1, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7308263
Registration DateTuesday, February 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases for clinical, medicinal, therapeutic, vaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, for clinical, medicinal, theapeutic, vaccine, and vaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseases, namely, cancer, and infectious diseases; biological preparations for medical purposes, namely, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 21, 2022
Primary Code005
First Use Anywhere DateTuesday, January 18, 2022
First Use In Commerce DateTuesday, July 19, 2022

Trademark Owner History


Party NameAltor BioScience, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 92032

Party NameAltor BioScience, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 92032

Party NameAltor BioScience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 92032

Trademark Events


Event DateEvent Description
Monday, September 5, 2022NEW APPLICATION ENTERED
Wednesday, September 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Saturday, June 17, 2023NON-FINAL ACTION WRITTEN
Saturday, June 17, 2023NON-FINAL ACTION E-MAILED
Saturday, June 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED